ALPINE IMMUNE SCIENCES, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2016 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2016 to Q1 2024.
  • Alpine Immune Sciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 64M shares, a 34.6% increase year-over-year.
  • Alpine Immune Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 50M shares, a 49.5% increase from 2022.
  • Alpine Immune Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 33.4M shares, a 31.2% increase from 2021.
  • Alpine Immune Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 25.5M shares, a 22.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 64M +16.5M +34.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 50M +16.6M +49.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 49.2M +17.6M +55.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 48M +17.7M +58.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 47.6M +17.3M +57.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 33.4M +7.96M +31.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 31.6M +6.85M +27.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 30.3M +6.42M +26.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 30.3M +6.4M +26.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 25.5M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-20
Q3 2021 24.7M +2.45M +11% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 23.9M +5.32M +28.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 23.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 22.3M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 18.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q3 2018 13.9M +2.26M +19.5% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q3 2017 11.6M +11M +1804% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q3 2016 609K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.